Literature DB >> 1348415

Expression of intercellular adhesion molecule-1 in thyroid follicular cells in autoimmune, non-autoimmune and neoplastic diseases of the thyroid gland: discordance with HLA.

E Tolosa1, C Roura, M Catálfamo, M Martí, A Lucas-Martín, A Sanmartí, I Salinas, G Obiols, M Foz-Sala, R Pujol-Borrell.   

Abstract

The presence of intercellular adhesion molecule-1 (ICAM-1) on epithelial cells facilitates their recognition by specific T lymphocytes. To assess the possible role of ICAM-1 in the recognition of thyroid follicular cells by T cells in thyroid autoimmune disease, we investigated the expression of ICAM-1 in thyrocytes from thyroid glands affected by Graves' disease, in glands with non-autoimmune pathology and normal glands using immunofluorescence staining on cryostat sections and on dispersed cell preparations. Sequential tissue sections from glands affected by Graves' disease (n = 15), multinodular goitre (MNG, n = 26), benign nodules (n = 11), primary carcinomas (n = 12) and control thyroid glands (n = 5) were stained for ICAM-1, HLA class I, HLA class II, CD3 and thyroid peroxidase (TPO). Weak and patchy ICAM-1 expression was found in the thyrocytes of 4/15 (27%) Graves' disease and of 1/26 (4%) multinodular goitre glands. In contrast, ICAM-1 expression was detected in the thyrocytes of 5/11 (45%) benign nodules and of 8/12 (67%) thyroid carcinomas in which it was sometimes strong. Thyrocytes in the five control glands were negative. These results correlated well with flow cytometry data from 23 of these glands which showed that ICAM-1 expression in thyrocytes from Graves' patients was, when present, 'dull', while in some malignant thyrocytes it was 'bright'. In preparations of thyrocytes from Graves' disease glands we found a striking discordance between the high levels of expression of HLA class I and HLA class II and the low expression of ICAM-1. This is surprising since in vitro the expression of these three molecules is equally induced by IFN-gamma and TNF-alpha. These results suggest that additional factors are involved in the induction of the inappropriate HLA class II expression observed in the thyrocytes of glands affected by Graves' disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1348415     DOI: 10.1016/s0896-8411(05)80055-1

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  12 in total

1.  Immunohistochemical analysis of intercellular adhesion molecule-1 expression in human gastric adenoma and adenocarcinoma.

Authors:  R Nasu; M Mizuno; T Kiso; K Shimo; T Uesu; J Nasu; J Tomoda; H Okada; T Tsuji
Journal:  Virchows Arch       Date:  1997-04       Impact factor: 4.064

2.  Phenothiazine-induced increase in thyroid autoantigens and costimulatory molecules on thyroid cells: a pathophysiological mechanism for drug-induced autoimmunity?

Authors:  L Takorabet; A Ropars; L Stasiuk; C Raby; J Charreire
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

3.  Expression of ICAM-1 in distant metastatic thyroid carcinoma.

Authors:  J M Fernández-Real; C Villabona; M Fernández-Castañer; E Sagarra; J M Gómez-Saéz; J Soler
Journal:  J Endocrinol Invest       Date:  1996-03       Impact factor: 4.256

4.  One-tube-PCR technique for CCL2, CCL3, CCL4 and CCL5 applied to fine needle aspiration biopsies shows different profiles in autoimmune and non-autoimmune thyroid disorders.

Authors:  X Ferrer-Francesch; P Caro; L Alcalde; M P Armengol; Y Ashhab; A Lucas-Martín; E M Martínez-Cáceres; M Juan; R Pujol-Borrell
Journal:  J Endocrinol Invest       Date:  2006-04       Impact factor: 4.256

5.  Different intrathyroid expression of intercellular adhesion molecule-1 (ICAM-1) in Hashimoto's thyroiditis and Graves' disease: analysis at mRNA level and association with B7.1 costimulatory molecule.

Authors:  G Pesce; N Fiorino; A M Riccio; P Montagna; G Torre; C Salmaso; V Altrinetti; M Bagnasco
Journal:  J Endocrinol Invest       Date:  2002-03       Impact factor: 4.256

6.  Gamma delta lymphocytes in endocrine autoimmunity: evidence of expansion in Graves' disease but not in type 1 diabetes.

Authors:  I C Roura-Mir; L Alcalde; F Vargas; E Tolosa; G Obiols; M Foz; D Jaraquemada; R Pujol-Borrell
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

7.  Soluble intercellular adhesion molecule-1 (sICAM-1) in sera of patients with Graves' ophthalmopathy and thyroid diseases.

Authors:  A E Heufelder; R S Bahn
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

8.  Expression of adhesion molecule ICAM-1 (CD54) in thyroid papillary adenocarcinoma.

Authors:  M Nakashima; K Eguchi; N Ishikawa; I Yamashita; M Sakai; H Ida; Y Kawabe; K Ito; S Nagataki
Journal:  J Endocrinol Invest       Date:  1994-12       Impact factor: 4.256

9.  Intercellular adhesion molecule-1 (ICAM-1) in Graves' disease: contrast between in vivo and in vitro results.

Authors:  A Ciampolillo; G Napolitano; R Mirakian; A Miyasaki; R Giorgino; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

10.  Characterization of neural cell adhesion molecule (NCAM) expression in thyroid follicular cells: induction by cytokines and over-expression in autoimmune glands.

Authors:  F Vargas; E Tolosa; M Sospedra; M Catálfamo; A Lucas-Martín; G Obiols; R Pujol-Borrell
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.